Tumor control probability for permanent implants in prostate

Area of Science:

• Oncology
• Radiation Oncology
• Medical Physics

Background:

• Permanent prostate brachytherapy using Iodine-125 (125I) seeds is a treatment modality for localized prostate cancer.
• Understanding tumor control probabilities (TCPs) is crucial for optimizing radiation therapy outcomes.
• Previous studies have focused on retropubic implant techniques, necessitating updated data for newer approaches.

Purpose of the Study:

• To compute tumor control probabilities (TCPs) for transperineal permanent prostate implants using 125I seeds.
• To compare the efficacy of transperineal implants with historical retropubic implant data.
• To provide a basis for further refinement and validation of predictive models for prostate cancer treatment.

Main Methods:

• Utilized target-specific volume-dose histogram data for 11 transperineal permanent prostate implant cases.
• Converted prostate dose-response data from external beam therapy using the alpha beta model to derive biologically effective dose.
• Compared calculated TCPs with data from 679 previous retropubic implants.

Main Results:

• Computed TCPs for 11 transperineal prostate implants using 125I seeds.
• Established a comparison between transperineal and retropubic prostate implant techniques based on calculated TCPs.
• Identified areas for model refinement based on initial findings.

Conclusions:

• The study provides initial tumor control probability data for transperineal prostate implants with 125I seeds.
• Comparative analysis offers insights into the relative effectiveness of transperineal versus retropubic brachytherapy techniques.
• Long-term patient follow-up data are required for comprehensive model validation and clinical application.